1-tetradecanoyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine

Metabolite details

Identifier

HAIPHKFLSXSDAN-BLOCXYQCSA-N

InChI Key

HAIPHKFLSXSDAN-BLOCXYQCSA-N

IUPAC name

(2R)-2-{[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy}-3-(tetradecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate

Preferred name

1-tetradecanoyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine

INN name

—

Synonym

PC(14:0/22:6)

ChEBI

CHEBI:86162

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• A multi-omics approach to study peroxisome proliferator-activated receptor mediated regulation of lipid metabolism in Atlantic cod (Gadus morhua)
• Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
• Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole
• Metabolic characterization of the natural progression of chronic hepatitis B (Lipid assays).
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• RNA-Seq and UHPLC-Q-TOF/MS Based Lipidomics Study in Lysiphlebia japonica.
• Lipidomics and RNA-Seq Study of Lipid Regulation in Aphis gossypii parasitized by Lysiphlebia japonica
• Transcript variants of long-chain acyl-CoA synthase 1 have distinct roles in sheep lipid metabolism
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• Control_Plasma_vs_WY-14,643_Plasma
• Control_vs_AONFH_Stage_III_IV
• Control_vs_AONFH_Stage_III_IV
• WT_vs_WT_Aco
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Normal_control_no_tumor_vs_FH_deficient_RCC
• Larva_vs_Pupa
• Unparasitized_vs_Parasitized
• Knockdown_vs_Control
• Knockdown_vs_Control
• BSA_Control_vs_AA